Group items tagged

"Medicine X is Stanford University's premier health care innovation program focusing on the intersection of emerging technologies and medicine. Our initiative is a catalyst for new ideas, and explores how we can work together to advance the practice of medicine, implement new approaches to healthcare such as precision medicine, and empower all stakeholders to be active participants in discussions about the future of health care. Under the direction of Dr. Larry Chu, Associate Professor of Anesthesia at Stanford School of Medicine, and guided by the Everyone Included™ framework for co-creation and leadership, Medicine X is a project of the Stanford AIM Lab and a growing international community."

"Our mission is to improve public health through prevention research, education, and clinical care." The department's clinical care and community-based initiatives aim to transform health care in San Diego through the practice of family medicine, preventive medicine, sports medicine, integrative medicine, and research that is practice-based. We have a robust portfolio of innovative clinical and public health focused research projects that address contemporary public health challenges through tools from biostatistics/bioinformatics, behavioral medicine, epidemiology, policy, and dissemination and implementation science. We have established Centers of Excellence in cardiovascular epidemiology, health behavior and equity, integrative health, tobacco control, wireless and population health, and women's health. Innovative, interdisciplinary partnerships are ongoing with Qualcomm Institute/Calit2, Moores Cancer Center, the Scripps Institute of Oceanography, Center for Microbiome Innovation, and many other departments.

Background With the rise of precision medicine efforts worldwide, our study objective was to describe and map the emerging precision medicine landscape. A Google search was conducted between June 19, 2017 to July 20, 2017 to examine how "precision medicine" and its analogous terminology were used to describe precision medicine efforts. Resulting web-pages were reviewed for geographic location, data type(s), program aim(s), sample size, duration, and the key search terms used and recorded in a database. Descriptive statistics were applied to quantify terminology used to describe specific precision medicine efforts. Qualitative data were analyzed for content and patterns.

"People Science is a tech-led platform that will connect health minded people, research scientists, and healthcare providers in an effort to unlock the potential of alternative medicines. Too little is known about alternative medicines like medical cannabis, prebiotics and probiotics, nutritional supplements, psychedelics, and other plant-based medicines. That's about to change. Our goal is to help people understand which alternative medicines can best help them on their path to wellness. Doctors will learn more too. By connecting health minded people with doctors and research scientists on our cutting edge platform, C.H.L.O.E., we will advance our collective knowledge of alternative medicines. This will also assist manufacturers to develop better products backed by rigorous scientific testing and research."

"Building on the successes of our events in Philadelphia and Jersey City, we are excited to be back where it all began - San Diego.  Please join us for the most thought-provoking Precision Medicine event in the marketplace. Our speakers cover the panoply of leaders in the healthcare continuum, these include clinicians, industry experts, academics, regulators, payers, genetic counselors, bioinformaticians, and many more who are shaping the way Precision Medicine is implemented into healthcare systems on a global scale. Join us for panel discussions, keynotes, "Meet the Expert", roundtables, networking, exhibits, and opening reception to hear from thought leaders who are making the promise of Precision Medicine a reality. "

"David Fajgenbaum, MD, MBA, MSc, is the co-founder and Executive Director of the Castleman Disease Collaborative Network (CDCN) and one of the youngest individuals to be appointed to the faculty at Penn Medicine, where he is an Assistant Professor of Medicine in Translational Medicine & Human Genetics, Founding Director of the Center for Study & Treatment of Castleman & inflammatory Lymphadenopathies (CSTL). An NIH-funded physician-scientist, he has dedicated his life to discovering new treatments and cures for deadly disorders like idiopathic multicentric Castleman disease (iMCD), which he was diagnosed with during medical school. As common as ALS and more deadly than lymphoma, iMCD involves the immune system attacking and shutting down the body's vital organs such as the liver, kidneys, bone marrow, and heart. After spending months hospitalized in critical condition, having his last rites read, and having four deadly relapses, he is now in his longest remission ever thanks to a treatment that he identified in the lab."

The UnDx Consortium The UnDx Consortium™ is an initiative of precision medicine technology companies and scientists to explore how a multidisciplinary approach to precision medicine can provide information and answers for patients with undiagnosed diseases. is an initiative of precision medicine technology companies and scientists to explore how a multidisciplinary approach to precision medicine can provide information and answers for patients with undiagnosed diseases.

Recommended by DeAunne Denmark, MD, PhD. Eric Topol's professional background: Gary & Mary West Endowed Chair of Innovative Medicine, Scripps Research Executive VP, Scripps Research Professor, Molecular Medicine, Scripps Research Director & Founder, Scripps Research Translational Institute Department of Molecular Medicine California Campus

"www.education.med.bc.ca" Our mighty EdTech team produces cinematic educational experiences: video, audio, interactive, simulated, narrative & virtual. We welcome collaborations from our international learning community. The Digital Solutions' EdTech team facilitates innovation by UBC Medicine learners and faculty. Website: www.education.med.bc.ca Subscribe: https://www.youtube.com/ubcmedvid?sub_confirmation=1 UBCMLN Podcast Network: https://tinyurl.com/ubcmedicinelearningnetwork Follow us for more content on all social media channels: @ubcmedvid The UBC Medical Program is situated on the traditional territories of indigenous peoples. We honour our hosts' graciousness for the students who seek knowledge here. © 2013-2022 UBC Faculty of Medicine, University of British Columbia. Vancouver, Canada. All rights reserved. Reproduction & distribution of this presentation without written permission from UBC Faculty of Medicine is prohibited.

UC San Diego School of Medicine has long been known as a place where discoveries are made. Today, we are known as a place where discoveries are delivered. UC San Diego School of Medicine, established in 1968, is the region's only medical school. As a top-tier academic medical center, our role is to improve health through innovative research, education and patient care.

"Melanie R. Fiorella, MD Primary Care Physician Assistant Professor of Family Medicine and Public Health Specialties: Primary Care Family Medicine (Primary Specialty) Integrative & Holistic Medicine Pediatrics"

"Every patient has a story Medicine used to be a one-size fits all model. Disease X meant treatment Y. Doctors made decisions and patients listened.  Clinical trials were our only data source. But those days are over. Medicine has gotten personal.   Today, we know  that every patient has a unique medical story. The best care requires knowing those stories and the next generation of medical discovery requires compiling those stories into structured data sets.   That's why PicnicHealth works directly with patients to gather and manage complete, up-to-date medical records. That's also why with our PicnicAI platform, we go beyond serving patients directly, and partner with the most innovative Life Sciences companies to sponsor PicnicHealth accounts for groups of research volunteers. Only by putting patients in control of their own data will we move beyond fragmented, unstructured medical records for both individual patient benefit today and for the opportunity to meaningfully contribute to tomorrow's medicine."

"The relationship between doctors and patients has eroded over recent decades, with minimal time and keyboards as the main culprits. Physicians-and all clinicians-are experiencing burnout at increasing rates, and superficial contact with patients is resulting in diagnostic errors and unnecessary tests and procedures. In his latest book, Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again, Eric Topol, MD, reveals how artificial intelligence (AI) can help restore the critical human connection between doctor and patient. Described by many in the medical field as a futurist, Topol gives readers a deep dive into how AI will not only transform the practice of medicine, but also radically reshape health systems and impact biomedical research."

Recommended by: DeAunne Denmark, MD, PhD "It's important for the public to be aware of what's available to them in the world of genomics and precision medicine. Various resources are available that provide general and disease-specific information about genomics and precision medicine. A list of some resources available to the public is provided below, but additional resources are likely available through your health provider or other groups such as the US National Institutes of Health."

The resource index in this article is incredible.

"Biomedical Ethics Seminar Series: Special Event  End of Life Liberty: Empowering Dying Patients with Choices. An overview of the evolving changes in law and medicine governing patient autonomy at the end of life over the past 2 decades. What has been learned? What changes ought be considered? Can we move to normalize the practice of aid in dying within the practice of medicine? Do some states offer a model for practice governed by standard of care? Do psychedelic medicines offer a new palliative tool for patients with anxiety? What is the status of the research, and federal, state and local law governing psychedelic substances.

"Although each effort is being conducted separately, all of the studies center around a common principle that by establishing a baseline set of biometrics for every study participant - including temperature, heart rate, and activity and sleep levels - researchers can detect deviations that are suggestive of illness." "Forget precision medicine. This is precision health," said Michael Snyder, Stanford University School of Medicine genetics department chair and director of genomics and personalized medicine.

""Excitement for precision medicine must be matched with clear-eyed examinations of the possibility for this emerging field to exacerbate existing risks…or create new points of vulnerability.""

"To keep pace with the evolving ecosystem for precision medicine, pharma players must be attuned to three crucial components: data collection, individualized solutions, and supporting business models."

"N-of-1 or single subject clinical trials consider an individual patient as the sole unit of observation in a study investigating the efficacy or side-effect profiles of different interventions. The ultimate goal of an n-of-1 trial is to determine the optimal or best intervention for an individual patient using objective data-driven criteria. Such trials can leverage study design and statistical techniques associated with standard population-based clinical trials, including randomization, washout and crossover periods, as well as placebo controls. Despite their obvious appeal and wide use in educational settings, n-of-1 trials have been used sparingly in medical and general clinical settings. We briefly review the history, motivation and design of n-of-1 trials and emphasize the great utility of modern wireless medical monitoring devices in their execution. We ultimately argue that n-of-1 trials demand serious attention among the health research and clinical care communities given the contemporary focus on individualized medicine. Keywords: clinical equipoise, early-phase trials, individualized medicine, n-of-1, remote phenotyping, single patient trial, treatment repositioning, wireless health"

"The Center for Integrative Medicine operates virtually across UC San Diego's departments and divisions, focusing on whole-person wellness by addressing your physical, as well as lifestyle, emotional, psychological and spiritual needs. Blending the science of medicine with the art of healing creates an environment throughout UC San Diego's community that not only supports the best in clinical care, but also offers opportunities for research, education and community partnerships."